Arvinas (ARVN) Prepaid Assets (2017 - 2026)
Arvinas (ARVN) recorded quarterly Prepaid Assets of $9.4 million in Q1 2026, up 5.62% quarter-over-quarter from $8.9 million in Q4 2025, and down 44.71% on a YoY basis from $17.0 million in Q1 2025.
Arvinas (ARVN) Prepaid Assets (2017 - 2026) Analysis & Trends
Arvinas' Prepaid Assets history runs 10 years deep, the most recent figure standing at $9.4 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 44.71% year-over-year to $9.4 million; the TTM figure through Mar 2026 stood at $9.4 million (down 44.71% YoY), while the FY2025 annual figure was $8.9 million, down 37.32% from the prior year.
- Prepaid Assets was $9.4 million for Q1 2026 at Arvinas, up from $8.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $21.7 million in Q3 2022 to a low of $6.5 million in Q4 2023.
- Historically, Prepaid Assets has averaged $13.6 million across 5 years, with a median of $13.1 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets tumbled 69.63% in 2023, then surged 118.46% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $21.4 million in 2022, then sank by 69.63% to $6.5 million in 2023, then surged by 118.46% to $14.2 million in 2024, then plunged by 37.32% to $8.9 million in 2025, then climbed by 5.62% to $9.4 million in 2026.
- The last three Prepaid Assets figures came in at $9.4 million (Q1 2026), $8.9 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.40 Mn |
| Dec 31, 2025 | 8.90 Mn |
| Sep 30, 2025 | 11.90 Mn |
| Jun 30, 2025 | 17.20 Mn |
| Mar 31, 2025 | 17.00 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Sep 30, 2024 | 13.10 Mn |
| Jun 30, 2024 | 12.50 Mn |
| Mar 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 8.40 Mn |
| Jun 30, 2023 | 7.60 Mn |
| Mar 31, 2023 | 14.50 Mn |
| Dec 31, 2022 | 21.40 Mn |
| Sep 30, 2022 | 21.70 Mn |
| Jun 30, 2022 | 20.60 Mn |
| Mar 31, 2022 | 17.40 Mn |
| Dec 31, 2021 | 19.70 Mn |
| Sep 30, 2021 | 18.54 Mn |
| Jun 30, 2021 | 15.24 Mn |